A minimally invasive treatment option for large metastatic brain tumors: Long-term results of two-session Gamma Knife stereotactic radiosurgery

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Yomo, Shoji ^a   Hayashi, Motohiro ^b  

^a Aizawa Hospital   (Japan)

^b San ai Hospital   (Japan)

Author keywords

Brain metastases; Gamma knife; Stereotactic radiosurgery

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTRAST ENHANCEMENT; DAILY LIFE ACTIVITY; DETERIORATION; FEMALE; FOLLOW UP; GAMMA KNIFE; GAMMA KNIFE RADIOSURGERY; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; MINIMALLY INVASIVE PROCEDURE; MULTIMODALITY CANCER THERAPY; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; OVERALL SURVIVAL; PRIMARY TUMOR; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY; SALVAGE THERAPY; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TREATMENT FAILURE; VOMITING; BRAIN NEOPLASMS; CANCER STAGING; DISEASE COURSE; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; MORTALITY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PATHOLOGY; PROGNOSIS; RADIOSURGERY; SECONDARY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 84902577719     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-132     Document Type: Article

References (31)

1. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47:291-298. 10.1016/S0360-3016(99)00507-6, 10802351.
2. Wiggenraad R, Verbeek-de Kanter A, Kal HB, Taphoorn M, Vissers T, Struikmans H. Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 2011, 98:292-297. 10.1016/j.radonc.2011.01.011, 21316787.
3. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 2006, 81:18-24. 10.1016/j.radonc.2006.08.024, 16978720.
4. Higuchi Y, Serizawa T, Nagano O, Matsuda S, Ono J, Sato M, Iwadate Y, Saeki N. Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors. Int J Radiat Oncol Biol Phys 2009, 74:1543-1548. 10.1016/j.ijrobp.2008.10.035, 19135317.
5. Kim YJ, Cho KH, Kim JY, Lim YK, Min HS, Lee SH, Kim HJ, Gwak HS, Yoo H, Lee SH. Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 2011, 81:483-489. 10.1016/j.ijrobp.2010.05.033, 20800386.
6. Fokas E, Henzel M, Surber G, Kleinert G, Hamm K, Engenhart-Cabillic R. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases. J Neurooncol 2012, 109:91-98. 10.1007/s11060-012-0868-6, 22528795.
7. Wegner RE, Leeman JE, Kabolizadeh P, Rwigema JC, Mintz AH, Burton SA, Heron DE. Fractionated Stereotactic Radiosurgery for Large Brain Metastases. Am J Clin Oncol 2013,
8. Oermann EK, Kress MA, Todd JV, Collins BT, Hoffman R, Chaudhry H, Collins SP, Morris D, Ewend MG. The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastases. J Neurosurg 2013, 119:1131-1138. 10.3171/2013.8.JNS122177, 24010977.
9. Yomo S, Hayashi M, Nicholson C. A prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors. J Neurooncol 2012, 109:159-165. 10.1007/s11060-012-0882-8, 3402679, 22544651.
10. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751. 10.1016/S0360-3016(96)00619-0, 9128946.
11. Brenner DJ, Martel MK, Hall EJ. Fractionated regimens for stereotactic radiotherapy of recurrent tumors in the brain. Int J Radiat Oncol Biol Phys 1991, 21:819-824. 10.1016/0360-3016(91)90703-7, 1869472.
12. Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?. Int J Radiat Oncol Biol Phys 2014, 88:254-262. 10.1016/j.ijrobp.2013.07.022, 24411596.
13. Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 2008, 49:694-699. 10.2967/jnumed.107.048082, 18413375.
14. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1141-1154.
15. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
16. Yang HC, Kano H, Lunsford LD, Niranjan A, Flickinger JC, Kondziolka D. What factors predict the response of larger brain metastases to radiosurgery?. Neurosurgery 2011, 68:682-690. discussion 690, 10.1227/NEU.0b013e318207a58b, 21311296.
17. Han JH, Kim DG, Kim CY, Chung HT, Jung HW. Stereotactic radiosurgery for large brain metastases. Prog Neurol Surg 2012, 25:248-260.
18. Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, Cobbs CS, Ammirati M, Robinson PD, Andrews DW, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Ryken TC, Linskey ME. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96:33-43. 10.1007/s11060-009-0061-8, 2808516, 19960230.
19. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485-1489.
20. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2011, 29:134-141. 10.1200/JCO.2010.30.1655, 3058272, 21041710.
21. Robbins JR, Ryu S, Kalkanis S, Cogan C, Rock J, Movsas B, Kim JH, Rosenblum M. Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis. Neurosurgery 2012, 71:937-943. 10.1227/NEU.0b013e31826909f2, 22806080.
22. Minniti G, Esposito V, Clarke E, Scaringi C, Lanzetta G, Salvati M, Raco A, Bozzao A, Maurizi Enrici R. Multidose stereotactic radiosurgery (9 Gy x 3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys 2013, 86:623-629. 10.1016/j.ijrobp.2013.03.037, 23683828.
23. Serizawa T, Higuchi Y, Ono J, Matsuda S, Nagano O, Iwadate Y, Saeki N. Gamma Knife surgery for metastatic brain tumors without prophylactic whole-brain radiotherapy: results in 1000 consecutive cases. J Neurosurg 2006, 105(Suppl):86-90.
24. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, Formenti SC. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 2004, 58:862-870. 10.1016/j.ijrobp.2003.09.012, 14967443.
25. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer cell 2005, 8:89-91. 10.1016/j.ccr.2005.07.014, 16098459.
26. Sugie C, Shibamoto Y, Ito M, Ogino H, Miyamoto A, Fukaya N, Niimi H, Hashizume T. Radiobiologic effect of intermittent radiation exposure in murine tumors. Int J Radiat Oncol Biol Phys 2006, 64:619-624. 10.1016/j.ijrobp.2005.03.032, 16414375.
27. Lee CC, Yen CP, Xu Z, Schlesinger D, Sheehan J. Large intracranial metastatic tumors treated by Gamma Knife surgery: outcomes and prognostic factors. J Neurosurg 2014, 120:52-59. 10.3171/2013.9.JNS131163, 24160478.
28. Sharpton SR, Oermann EK, Moore DT, Schreiber E, Hoffman R, Morris DE, Ewend MG. The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications. Neurosurgery 2014, 74:9-15. discussion 16; quiz 16, 10.1227/NEU.0000000000000190, 24077581.
29. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514. 10.1016/j.ijrobp.2007.06.074, 17931798.
30. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR, Jackson EF. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 2011, 79:1487-1495. 10.1016/j.ijrobp.2009.12.061, 2908725, 20399573.
31. Deibert CP, Ahluwalia MS, Sheehan JP, Link MJ, Hasegawa T, Yomo S, Feng WH, Li P, Flickinger JC, Lunsford LD, Kondziolka D. Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery. J Neurooncol 2013, 115:217-223. 10.1007/s11060-013-1214-3, 23929592.